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INVITED COMMENTARY
Peter Neglen, MD, PhD, Flowood, Miss
This study is inspired by the findings following endovenous
ablation of the great saphenous vein (GSV), which has shown
that there is no disadvantage leaving a longer GSV stump and
tributaries draining the abdominal wall intact. It may even be
preferable to do so, since neovascularization at the groin level
rarely occurs with this procedure. In this report, the routine
surgical flush ligation has, therefore, been replaced by a lower
ligation placed above the highest descending branch leaving a
remnant of the GSV. The authors assume that it is the placement
of the tie rather than the surgical trauma in itself, which is the
deciding factor. The authors have shown that this procedure is
safe, gives symptom relief, and results in a good aesthetic result
in the short term, but that is, however, true for most interven-
tions on the GSV. The observation period is too short to assess
the important end points, ie, avoidance of neovascularization
and late recurrence of varicosities. Ultimately, only a random-
ized study can validate this concept.
I have some methodological concerns regarding adherence to
reporting standards. The way the CEAP classification was origi-
nally constructed prohibits the use of the C-class for serial evalua-
tion, and it must not be used for this purpose. Several other scores,
eg, Venous Clinical Severity Score (VCSS), quality of life scores,
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visual analogue scales etc, are developed for this intention. I laud
the authors for using the Kaplan-Meier analysis for postoperative
follow-up. However, it appears as though only patients followed
for more than 1 year are included in the result presentation, ie,
43% of the operated patients is ignored. Also, the actuarial
analysis seems only to be applied to these patients. This weakens
the results considerably. The rate of sapheno-femoral conflu-
ence (SFC) recurrence and varicose vein recurrence is given as
2% and 6%, respectively. Approximation from the cumulative
curve indicates at 32 months rates of 3% and 13%, respectively.
It would have been better if all patients had been included in the
final analysis.
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